Literature DB >> 7641030

FDA expands access to gemcitabine for pancreatic cancer.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7641030     DOI: 10.1093/ajhp/52.9.931

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


× No keyword cloud information.
  1 in total

1.  Validation of Polo-like kinase 1 as a therapeutic target in pancreatic cancer cells.

Authors:  Chao Zhang; Xiaodong Sun; Yuan Ren; Yunbo Lou; Jun Zhou; Min Liu; Dengwen Li
Journal:  Cancer Biol Ther       Date:  2012-08-15       Impact factor: 4.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.